Manulife (Manufacturers Life Insurance)
SUPN icon

Manulife (Manufacturers Life Insurance)’s Supernus Pharmaceuticals SUPN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
27,907
+2,401
+9% +$115K ﹤0.01% 1833
2026
Q1 		$1.32M Sell
25,506
-296
-1% -$15.1K ﹤0.01% 1686
2025
Q4 		$1.28M Sell
25,802
-1,181
-4% -$57.4K ﹤0.01% 1733
2025
Q3 		$1.29M Sell
26,983
-1,503
-5% -$60.5K ﹤0.01% 1720
2025
Q2 		$898K Buy
28,486
+2,577
+10% +$82.6K ﹤0.01% 1870
2025
Q1 		$849K Buy
25,909
+668
+3% +$23.7K ﹤0.01% 1885
2024
Q4 		$913K Sell
25,241
-797
-3% -$28.1K ﹤0.01% 1946
2024
Q3 		$812K Sell
26,038
-516
-2% -$16.1K ﹤0.01% 2028
2024
Q2 		$710K Buy
26,554
+1,870
+8% +$54.2K ﹤0.01% 2041
2024
Q1 		$842K Sell
24,684
-228
-0.9% -$6.79K ﹤0.01% 1943
2023
Q4 		$721K Sell
24,912
-881
-3% -$23.4K ﹤0.01% 1996
2023
Q3 		$711K Buy
25,793
+5,631
+28% +$171K ﹤0.01% 1944
2023
Q2 		$606K Buy
20,162
+335
+2% +$11.7K ﹤0.01% 1926
2023
Q1 		$718K Buy
19,827
+91
+0.5% +$3.5K ﹤0.01% 1788
2022
Q4 		$704K Buy
19,736
+230
+1% +$7.99K ﹤0.01% 1785
2022
Q3 		$660K Sell
19,506
-325
-2% -$10.6K ﹤0.01% 1807
2022
Q2 		$574K Sell
19,831
-406
-2% -$11.6K ﹤0.01% 1958
2022
Q1 		$654K Sell
20,237
-4,873
-19% -$149K ﹤0.01% 2014
2021
Q4 		$732K Sell
25,110
-690
-3% -$20.9K ﹤0.01% 2026
2021
Q3 		$688K Sell
25,800
-1,929
-7% -$51.8K ﹤0.01% 2065
2021
Q2 		$854K Sell
27,729
-130
-0.5% -$3.98K ﹤0.01% 2085
2021
Q1 		$729K Sell
27,859
-1,746
-6% -$48.8K ﹤0.01% 2058
2020
Q4 		$745K Buy
29,605
+733
+3% +$15.8K ﹤0.01% 1986
2020
Q3 		$602K Sell
28,872
-464
-2% -$10.5K ﹤0.01% 1905
2020
Q2 		$683K Sell
29,336
-2,331
-7% -$51.5K ﹤0.01% 1795
2020
Q1 		$570K Buy
31,667
+1,815
+6% +$38.1K ﹤0.01% 1766
2019
Q4 		$708K Sell
29,852
-820
-3% -$19.9K ﹤0.01% 1855
2019
Q3 		$843K Sell
30,672
-362
-1% -$10.7K ﹤0.01% 1733
2019
Q2 		$1.03M Sell
31,034
-1,143
-4% -$39.2K ﹤0.01% 1642
2019
Q1 		$1.13M Buy
32,177
+1,974
+7% +$73.4K ﹤0.01% 1623
2018
Q4 		$1M Sell
30,203
-1,751
-5% -$75.3K ﹤0.01% 1583
2018
Q3 		$1.61M Sell
31,954
-4,552
-12% -$225K ﹤0.01% 1540
2018
Q2 		$2.18M Buy
36,506
+340
+0.9% +$17.6K ﹤0.01% 1467
2018
Q1 		$1.66M Sell
36,166
-853
-2% -$35.6K ﹤0.01% 1567
2017
Q4 		$1.48M Buy
37,019
+904
+3% +$35.7K ﹤0.01% 1632
2017
Q3 		$1.45M Sell
36,115
-535
-1% -$23.2K ﹤0.01% 1590
2017
Q2 		$1.58M Buy
36,650
+128
+0.4% +$4.56K ﹤0.01% 1554
2017
Q1 		$1.14M Buy
36,522
+4,269
+13% +$114K ﹤0.01% 1669
2016
Q4 		$815K Sell
32,253
-69
-0.2% -$1.54K ﹤0.01% 1777
2016
Q3 		$799K Sell
32,322
-228
-0.7% -$5.16K ﹤0.01% 1776
2016
Q2 		$663K Buy
32,550
+8,883
+38% +$158K ﹤0.01% 1856
2016
Q1 		$356K Buy
23,667
+175
+0.7% +$2.28K ﹤0.01% 2210
2015
Q4 		$316K Buy
23,492
+268
+1% +$4.14K ﹤0.01% 2323
2015
Q3 		$326K Buy
23,224
+443
+2% +$8.24K ﹤0.01% 2276
2015
Q2 		$386K Buy
22,781
+1,866
+9% +$26.6K ﹤0.01% 2302
2015
Q1 		$253K Buy
20,915
+574
+3% +$5.42K ﹤0.01% 2560
2014
Q4 		$169K Buy
20,341
+492
+2% +$4.13K ﹤0.01% 2764
2014
Q3 		$173K Buy
19,849
+8
+0% +$72 ﹤0.01% 2726
2014
Q2 		$217K Buy
19,841
+6,420
+48% +$57.2K ﹤0.01% 2656
2014
Q1 		$120K Sell
13,421
-372
-3% -$3.43K ﹤0.01% 2992
2013
Q4 		$104K Buy
13,793
+12,232
+784% +$85.5K ﹤0.01% 3056
2013
Q3 		$11K Sell
1,561
-289
-16% -$1.94K ﹤0.01% 3248
2013
Q2 		$12K Buy
+1,850
New +$10.9K ﹤0.01% 3164

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SUPN Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Supernus Pharmaceuticals (SUPN) stake by 9.4% in Q2 2026, buying an estimated $115K and bringing the position to 27,907 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Manulife (Manufacturers Life Insurance) first reported a position in SUPN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.18M in Q2 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 27,907 shares of Supernus Pharmaceuticals worth $1.3M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 2,401 Supernus Pharmaceuticals shares in Q2 2026, an estimated $115K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1833 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Supernus Pharmaceuticals position peaked at $2.18M in Q2 2018.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.